SEC Form 4 · accession 0001179110-15-004546

INOVIO PHARMACEUTICALS, INC. · INO

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — CFO

Period of report

Mar 5, 2015

Accepted (ET)

Mar 9, 2015 · 5:23 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001055726

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock	holding	—	—		—	21,388	D
Common Stock	holding	—	—		—	4,500	I	By Spouse

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Restricted Stock Unit^F1	—	Mar 5, 2015	A	25,000	A	—	—	Common Stock	25,000	25,000	D
Common Stock Options^F2	$7.56	Mar 5, 2015	A	60,000	A	Mar 5, 2015	Mar 5, 2025	Common Stock	60,000	60,000	D

F1Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 25,000 restricted stock units is as follows: 8,334 shares will vest on March 5, 2016; 8,333 shares will vest on March 5, 2017; 8,333 shares will vest on March 5, 2018. Vested units of restricted stock can be settled in shares of common stock, cash or a combination of both.
F2The vesting schedule for the 60,000 options is as follows: 15,000 shares vested on March 5, 2015; 15,000 shares will vest on March 5, 2016; 15,000 shares will vest on March 5, 2017; 15,000 shares will vest on March 5, 2018